Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes
Authors
Keywords
-
Journal
CANCER INVESTIGATION
Volume 33, Issue 7, Pages 294-302
Publisher
Informa UK Limited
Online
2015-06-05
DOI
10.3109/07357907.2015.1034869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer
- (2017) Raheleh Roudi et al. Cancer Biomarkers
- Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis
- (2013) Monireh Mohsenzadegan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- High Expression of Stem Cell Marker ALDH1 is Associated with Reduced BRCA1 in Invasive Breast Carcinomas
- (2012) Zahra Madjd et al. Asian Pacific Journal of Cancer Prevention
- Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma-their prognostic significance
- (2012) Koji Okudela et al. PATHOLOGY INTERNATIONAL
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer stem cells and cancer therapy
- (2011) Sara Soltanian et al. TUMOR BIOLOGY
- Progenitor stem cell marker expression by pulmonary carcinomas
- (2010) Andre L Moreira et al. MODERN PATHOLOGY
- Emerging strategies for the identification and targeting of cancer stem cells
- (2010) Jun Dou et al. TUMOR BIOLOGY
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- Both CD133+and CD133−subpopulations of A549 and H446 cells contain cancer-initiating cells
- (2009) Xiangjiao Meng et al. CANCER SCIENCE
- The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer☆☆☆
- (2009) Virginia Tirino et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
- (2008) Satori A Marchitti et al. Expert Opinion on Drug Metabolism & Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now